市場調査レポート

商品コード

希少疾患治療の市場規模：薬剤タイプ別、治療領域別、患者別、投与経路別－業界分析、地域展望、成長性、応用性、競合市場シェア、予測（2023年～2032年）

Rare Disease Treatment Market Size By Drug, By Therapeutic Area, By Patient, By Route of Administration, Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032

出版日: 2023年01月20日 | 発行: Global Market Insights Inc.

| ページ情報: 英文 225 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel (Single User License)

USD 4,850 759,170円

レポートPDFおよびExcelを1名様のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Multi User License)

USD 5,350 837,435円

レポートPDFおよびExcelを5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Enterprise User License)

USD 8,350 1,307,025円

レポートPDFおよびExcelを同一企業内のすべての方にご利用頂けるライセンスです。 100％子会社は同一企業とみなされます。 PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.53円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の希少疾患治療の市場規模は、世界中で希少疾病が増加していることから、2032年にかけて大きく成長すると予想されています。

また、欧州連合（EU）では、希少疾病の治療が医薬品の研究開発において最も活発で急成長している分野の一つとなっていることも影響すると予測されます。

当レポートでは、世界の希少疾患治療市場について調査分析し、市場分析、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

業界情勢（2018年～2032年）
業界の影響要因
- 促進要因
- 業界の潜在的リスク・課題
成長性分析
- 薬剤タイプ別
- 治療領域別
- 患者別
- 投与経路別
COVID-19影響分析
希少疾患治療の臨床試験シナリオ
規制状況
- 米国
- 欧州
- アジア太平洋地域
パイプライン分析
今後の市場動向
技術情勢
ベンダーマトリックス分析
疫学シナリオ
現在の治療法
償還シナリオ
- 北米
- 欧州
- アジア太平洋地域
- ラテンアメリカ
- 中東・アフリカ
ポーターの分析
PESTEL分析

第4章競合情勢（2021年）

イントロダクション
企業マトリックス分析（2021年）
企業の市場シェア
戦略ダッシュボード（2021年）

第5章希少疾患治療市場：薬剤タイプ別

主な薬剤タイプの動向
生物製剤
非生物製剤

第6章希少疾患治療市場：治療領域別

主な治療領域の動向
がん
血液関連疾患
中枢神経系（CNS）
呼吸器疾患
筋骨格系疾患
心血管疾患
その他

第7章希少疾患治療市場：患者別

主な患者の動向
成人
小児

第8章希少疾患治療市場：投与経路別

主な投与経路の動向
経口
注射

第9章希少疾患治療市場：地域別

主な地域の動向
北米
- 米国
- カナダ
欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- ポーランド
- スイス
- スウェーデン
アジア太平洋地域
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- インドネシア
- タイ
- ベトナム
ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- チリ
- コロンビア
- ペルー
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- イラン
- エジプト

第10章企業プロファイル

AbbVie Inc
Seagen Inc.
AstraZeneca plc
Alexion Pharmaceuticals, Inc
Amgen Inc
Baxter International
Bayer AG
Biogen
Bristol-Myers Squibb
Eli Lilly and Company
Hoffman-La-Roche
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co Inc.
Novartis AG
Novo Nordisk
Pfizer Inc.
Pharmacyclics LLC
Sanofi SA
Seagen Inc.
Takeda Pharmaceutical Company Limited
Vertex Pharmaceuticals Incorporated

図表

TABLE 201. Indonesia rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 202. Indonesia rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 203. Indonesia rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 204. Thailand rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 205. Thailand rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 206. Thailand rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 207. Thailand rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 208. Thailand rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 209. Thailand rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 210. Thailand rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 211. Thailand rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 212. Vietnam rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 213. Vietnam rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 214. Vietnam rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 215. Vietnam rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 216. Vietnam rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 217. Vietnam rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 218. Vietnam rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 219. Vietnam rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 220. Latin America rare disease treatment market size, by country, 2018 - 2024 (USD Million)
TABLE 221. Latin America rare disease treatment market size, by country, 2025 - 2032 (USD Million)
TABLE 222. Latin America rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 223. Latin America rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 224. Latin America rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 225. Latin America rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 226. Latin America rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 227. Latin America rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 228. Latin America rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 229. Latin America rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 230. Brazil rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 231. Brazil rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 232. Brazil rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 233. Brazil rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 234. Brazil rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 235. Brazil rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 236. Brazil rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 237. Brazil rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 238. Mexico rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 239. Mexico rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 240. Mexico rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 241. Mexico rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 242. Mexico rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 243. Mexico rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 244. Mexico rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 245. Mexico rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 246. Argentina rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 247. Argentina rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 248. Argentina rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 249. Argentina rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 250. Argentina rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 251. Argentina rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 252. Argentina rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 253. Argentina rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 254. Chile rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 255. Chile rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 256. Chile rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 257. Chile rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 258. Chile rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 259. Chile rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 260. Chile rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 261. Chile rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 262. Columbia rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 263. Columbia rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 264. Columbia rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 265. Columbia rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 266. Columbia rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 267. Columbia rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 268. Columbia rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 269. Columbia rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 270. Peru rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 271. Peru rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 272. Peru rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 273. Peru rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 274. Peru rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 275. Peru rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 276. Peru rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 277. Peru rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 278. Middle East and Africa rare disease treatment market size, by country, 2018 - 2024 (USD Million)
TABLE 279. Middle East and Africa rare disease treatment market size, by country, 2025 - 2032 (USD Million)
TABLE 280. Middle East and Africa rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 281. Middle East and Africa rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 282. Middle East and Africa rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 283. Middle East and Africa rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 284. Middle East and Africa rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 285. Middle East and Africa rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 286. Middle East and Africa rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 287. Middle East and Africa rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 288. South Africa rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 289. South Africa rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 290. South Africa rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 291. South Africa rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 292. South Africa rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 293. South Africa rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 294. South Africa rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 295. South Africa rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 296. Saudi Arabia rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 297. Saudi Arabia rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 298. Saudi Arabia rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 299. Saudi Arabia rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 300. Saudi Arabia rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 301. Saudi Arabia rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 302. Saudi Arabia rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 303. Saudi Arabia rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 304. UAE rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 305. UAE rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 306. UAE rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 307. UAE rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 308. UAE rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 309. UAE rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 310. UAE rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 311. UAE rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 312. Israel rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 313. Israel rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 314. Israel rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 315. Israel rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 316. Israel rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 317. Israel rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 318. Israel rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 319. Israel rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 320. Iran rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 321. Iran rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 322. Iran rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 323. Iran rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 324. Iran rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 325. Iran rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 326. Iran rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 327. Iran rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 328. Egypt rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 329. Egypt rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 330. Egypt rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 331. Egypt rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 332. Egypt rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 333. Egypt rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 334. Egypt rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 335. Egypt rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)

Charts & Figures

FIG. 1 GMI report coverage: Critical research elements
FIG. 2 Industry segmentation
FIG. 3 Top-down approach
FIG. 4 Market estimation and forecast methodology
FIG. 5 Market forecasting methodology
FIG. 6 Breakdown of primary participants
FIG. 7 Rare disease treatment industry 360 degree synopsis, 2018 - 2032
FIG. 8 Industry landscape, 2018 - 2032 (USD Million)
FIG. 9 Growth potential analysis, by drug type
FIG. 10 Growth potential analysis, by therapeutic area
FIG. 11 Growth potential analysis, by patient
FIG. 12 Growth potential analysis, by route of administration
FIG. 13 Porter's analysis
FIG. 14 PESTEL analysis
FIG. 15 Company matrix analysis, 2021
FIG. 16 Company market share analysis, 2021
FIG. 17 Strategy dashboard, 2021

Product Code: 3873

Rare Disease Treatment Market is anticipated to grow considerably through 2032 owing to the increasing prevalence of rare diseases across the globe. According to reports, there are almost 7,000 classified rare diseases, and approximately 70% are uncurable. In addition, several unknown diseases require more understanding and research to educate people regarding their occurrence. Besides, in the European Union, rare disease treatments are among the most active and fastest growing areas in drug R&D.

Additionally, key providers in the rare disease treatment industry are engaging in partnerships, mergers, and acquisitions and launching new products to stay competitive in the overall market. To cite an instance, in 2020, AstraZeneca Plc, one of the leading drugmakers, acquired rare-disease specialist Alexion Pharmaceuticals Inc. in a deal worth USD 39 billion. With this acquisition, the firm will add treatment for uncommon blood and immunological disorders to its portfolio.

Overall, the rare disease treatment industry is segmented in terms of drug type, therapeutic area, patient, route of administration, and region.

Based on the therapeutic area, the cancer segment accounted for over USD 94 billion in 2022 and is anticipated to grow considerably through 2032. The segmental growth will be due to the rising prevalence of rare cancer disorders across the globe. As per National Cancer Institute reports, rare cancer cases account for more than 25% of all cancer cases in the U.S.

In terms of the route of administration, the oral segment accounted for 55% revenue share in 2022. The oral route of administration is simple, convenient, safe, pain-free, self-administered, economical, requires no sterile precautions, and poses a minimal danger of acute drug reaction. These attributes are anticipated to propel its adoption in the ensuing years.

Regionally, the Asia Pacific rare disease treatment industry is projected to grow at over 11% CAGR from 2023 to 2032. Increasing cases of rare diseases, rising awareness for precise disease treatment, and favorable government policies are key factors supporting market expansion in this region. Besides, the development of manufacturing and medical operations, along with rising healthcare costs will also act as a key factor fueling the growth. As per IBEF, India's public spending on healthcare stood at 2.1% of the GDP in 2021-2022.

Furthermore, increasing privatization, expanding health insurance penetration, the constant shift towards attracting skilled health care providers, and an increasingly aging population more prone to several rare diseases will positively influence the overall industry outlook in the region.

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Rare disease treatment industry 360 degree synopsis, 2018-2032
- 2.1.1 Business trends
- 2.1.2 Drug type trends
- 2.1.3 Therapeutic area trends
- 2.1.4 Patient trends
- 2.1.5 Route of administration trends
- 2.1.6 Regional trends

Chapter 3 Rare Disease Treatment Industry Insights

3.1 Industry landscape, 2018 - 2032
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increase in the prevalence of rare diseases
  - 3.2.1.2 Favourable government policies
  - 3.2.1.3 Growing number of new drug launches
  - 3.2.1.4 Increasing R&D activities for novel therapeutics and drugs
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of awareness regarding rare disease treatment
  - 3.2.2.2 High cost of the drugs and therapy
3.3 Growth potential analysis
- 3.3.1 By drug type
- 3.3.2 By therapeutic area
- 3.3.3 By patient
- 3.3.4 By route of administration
3.4 COVID- 19 impact analysis
3.5 Clinical trials scenario for rare disease treatment
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
- 3.6.3 Asia Pacific
3.7 Pipeline analysis
3.8 Future market trends
3.9 Technology landscape
3.10 Vendor matrix analysis
3.11 Epidemiology scenario
3.12 Current therapies
3.13 Reimbursement scenario
- 3.13.1 North America
- 3.13.2 Europe
- 3.13.3 Asia Pacific
- 3.13.4 Latin America
- 3.13.5 MEA
3.14 Porter's analysis
3.15 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Company market share
4.4 Strategy dashboard, 2021

Chapter 5 Rare Disease Treatment Market, By Drug Type

5.1 Key drug type trends
5.2 Biologics
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Non-biologics
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Rare Disease Treatment Market, By Therapeutic Area

6.1 Key therapeutic area trends
6.2 Cancer
- 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Blood-related Disorders
- 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Central Nervous System (CNS)
- 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Respiratory Disorders
- 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Musculoskeletal Disorders
- 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Cardiovascular Disorders
- 6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.8 Others
- 6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Rare Disease Treatment Market, By Patient

7.1 Key patient trends
7.2 Adult
- 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Pediatric
- 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Rare Disease Treatment Market, By Route of Administration

8.1 Key route of administration trends
8.2 Oral
- 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Injectable
- 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Rare Disease Treatment Market, By Region

9.1 Key regional trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Poland
- 9.3.7 Switzerland
- 9.3.8 Sweden
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Indonesia
- 9.4.7 Thailand
- 9.4.8 Vietnam
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Chile
- 9.5.5 Colombia
- 9.5.6 Peru
9.6 MEA
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Israel
- 9.6.5 Iran
- 9.6.6 Egypt

Chapter 10 Company Profiles

10.1 AbbVie Inc
10.2 Seagen Inc.
10.3 AstraZeneca plc
10.4 Alexion Pharmaceuticals, Inc
10.5 Amgen Inc
10.6 Baxter International
10.7 Bayer AG
10.8 Biogen
10.9 Bristol-Myers Squibb
10.10 Eli Lilly and Company
10.11 Hoffman-La-Roche
10.12 GlaxoSmithKline plc
10.13 Johnson & Johnson
10.14 Merck & Co Inc.
10.15 Novartis AG
10.16 Novo Nordisk
10.17 Pfizer Inc.
10.18 Pharmacyclics LLC
10.19 Sanofi SA
10.20 Seagen Inc.
10.21 Takeda Pharmaceutical Company Limited
10.22 Vertex Pharmaceuticals Incorporated

Data Tables

TABLE 1. Product mapping
TABLE 2. Market revenue, by drug type (2022):
TABLE 3. Market share, by therapeutic area (2022):
TABLE 4. Market share, by patient (2022):
TABLE 5. Market share, by route of administration (2022)
TABLE 6. Market share, by region (2022):
TABLE 7. Global rare disease treatment market size, 2018 - 2024 (USD Million)
TABLE 8. Global rare disease treatment market size, 2025 - 2032 (USD Million)
TABLE 9. Global rare disease treatment market, by drug type, 2018 - 2024 (USD Million)
TABLE 10. Global rare disease treatment market, by drug type, 2025 - 2032 (USD Million)
TABLE 11. Global rare disease treatment market, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 12. Global rare disease treatment market, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 13. Global rare disease treatment market, by patient, 2018 - 2024 (USD Million)
TABLE 14. Global rare disease treatment market, by patient, 2025 - 2032 (USD Million)
TABLE 15. Global rare disease treatment market, by route of administration, 2018 - 2024 (USD Million)
TABLE 16. Global rare disease treatment market, by route of administration, 2025 - 2032 (USD Million)
TABLE 17. Global rare disease treatment market, by region, 2018 - 2024 (USD Million)
TABLE 18. Global rare disease treatment market, by region, 2025 - 2032 (USD Million)
TABLE 19. Industry impact forces
TABLE 20. Biologics market size, by region, 2018 - 2024 (USD Million)
TABLE 21. Biologics market size, by region, 2025 - 2032 (USD Million)
TABLE 22. Non-biologics market size, by region, 2018 - 2024 (USD Million)
TABLE 23. Non-biologics market size, by region, 2025 - 2032 (USD Million)
TABLE 24. Cancer market size, by region, 2018 - 2024 (USD Million)
TABLE 25. Cancer market size, by region, 2025 - 2032 (USD Million)
TABLE 26. Blood-related disorders market size, by region, 2018 - 2024 (USD Million)
TABLE 27. Blood-related disorders market size, by region, 2025 - 2032 (USD Million)
TABLE 28. Central nervous system market size, by region, 2018 - 2024 (USD Million)
TABLE 29. Central nervous system market size, by region, 2025 - 2032 (USD Million)
TABLE 30. Respiratory disorders market size, by region, 2018 - 2024 (USD Million)
TABLE 31. Respiratory disorders market size, by region, 2025 - 2032 (USD Million)
TABLE 32. Musculoskeletal disorders market size, by region, 2018 - 2024 (USD Million)
TABLE 33. Musculoskeletal disorders market size, by region, 2025 - 2032 (USD Million)
TABLE 34. Cardiovascular disorders market size, by region, 2018 - 2024 (USD Million)
TABLE 35. Cardiovascular disorders market size, by region, 2025 - 2032 (USD Million)
TABLE 36. Others market size, by region, 2018 - 2024 (USD Million)
TABLE 37. Others market size, by region, 2025 - 2032 (USD Million)
TABLE 38. Adult market size, by region, 2018 - 2024 (USD Million)
TABLE 39. Adult market size, by region, 2025 - 2032 (USD Million)
TABLE 40. Pediatric market size, by region, 2018 - 2024 (USD Million)
TABLE 41. Pediatric market size, by region, 2025 - 2032 (USD Million)
TABLE 42. Oral market size, by region, 2018 - 2024 (USD Million)
TABLE 43. Oral market size, by region, 2025 - 2032 (USD Million)
TABLE 44. Injectable market size, by region, 2018 - 2024 (USD Million)
TABLE 45. Injectable market size, by region, 2025 - 2032 (USD Million)
TABLE 46. North America rare disease treatment market size, by country, 2018 - 2024 (USD Million)
TABLE 47. North America rare disease treatment market size, by country, 2025 - 2032 (USD Million)
TABLE 48. North America rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 49. North America rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 50. North America rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 51. North America rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 52. North America rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 53. North America rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 54. North America rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 55. North America rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 56. U.S. rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 57. U.S. rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 58. U.S. rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 59. U.S. rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 60. U.S. rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 61. U.S. rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 62. U.S. rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 63. U.S. rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 64. Canada rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 65. Canada rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 66. Canada rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 67. Canada rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 68. Canada rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 69. Canada rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 70. Canada rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 71. Canada rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 72. Europe rare disease treatment market size, by country, 2018 - 2024 (USD Million)
TABLE 73. Europe rare disease treatment market size, by country, 2025 - 2032 (USD Million)
TABLE 74. Europe rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 75. Europe rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 76. Europe rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 77. Europe rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 78. Europe rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 79. Europe rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 80. Europe rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 81. Europe rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 82. Germany rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 83. Germany rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 84. Germany rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 85. Germany rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 86. Germany rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 87. Germany rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 88. Germany rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 89. Germany rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 90. UK rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 91. UK rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 92. UK rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 93. UK rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 94. UK rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 95. UK rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 96. UK rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 97. UK rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 98. France rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 99. France rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 100. France rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 101. France rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 102. France rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 103. France rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 104. France rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 105. France rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 106. Spain rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 107. Spain rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 108. Spain rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 109. Spain rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 110. Spain rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 111. Spain rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 112. Spain rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 113. Spain rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 114. Italy rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 115. Italy rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 116. Italy rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 117. Italy rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 118. Italy rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 119. Italy rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 120. Italy rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 121. Italy rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 122. Poland rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 123. Poland rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 124. Poland rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 125. Poland rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 126. Poland rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 127. Poland rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 128. Poland rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 129. Poland rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 130. Switzerland rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 131. Switzerland rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 132. Switzerland rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 133. Switzerland rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 134. Switzerland rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 135. Switzerland rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 136. Switzerland rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 137. Switzerland rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 138. Sweden rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 139. Sweden rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 140. Sweden rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 141. Sweden rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 142. Sweden rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 143. Sweden rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 144. Sweden rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 145. Sweden rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 146. Asia Pacific rare disease treatment market size, by country, 2018 - 2024 (USD Million)
TABLE 147. Asia Pacific rare disease treatment market size, by country, 2025 - 2032 (USD Million)
TABLE 148. Asia Pacific rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 149. Asia Pacific rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 150. Asia Pacific rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 151. Asia Pacific rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 152. Asia Pacific rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 153. Asia Pacific rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 154. Asia Pacific rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 155. Asia Pacific rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 156. China rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 157. China rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 158. China rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 159. China rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 160. China rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 161. China rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 162. China rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 163. China rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 164. Japan rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 165. Japan rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 166. Japan rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 167. Japan rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 168. Japan rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 169. Japan rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 170. Japan rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 171. Japan rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 172. India rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 173. India rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 174. India rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 175. India rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 176. India rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 177. India rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 178. India rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 179. India rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 180. Australia rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 181. Australia rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 182. Australia rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 183. Australia rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 184. Australia rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 185. Australia rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 186. Australia rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 187. Australia rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 188. South Korea rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 189. South Korea rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 190. South Korea rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 191. South Korea rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 192. South Korea rare disease treatment market size, by patient, 2018 - 2024 (USD Million)
TABLE 193. South Korea rare disease treatment market size, by patient, 2025 - 2032 (USD Million)
TABLE 194. South Korea rare disease treatment market size, by route of administration, 2018 - 2024 (USD Million)
TABLE 195. South Korea rare disease treatment market size, by route of administration, 2025 - 2032 (USD Million)
TABLE 196. Indonesia rare disease treatment market size, by drug type, 2018 - 2024 (USD Million)
TABLE 197. Indonesia rare disease treatment market size, by drug type, 2025 - 2032 (USD Million)
TABLE 198. Indonesia rare disease treatment market size, by therapeutic area, 2018 - 2024 (USD Million)
TABLE 199. Indonesia rare disease treatment market size, by therapeutic area, 2025 - 2032 (USD Million)
TABLE 200. Indonesia rare disease treatment market size, by patient, 2018 - 2024 (USD Million)

希少疾患治療の市場規模：薬剤タイプ別、治療領域別、患者別、投与経路別－業界分析、地域展望、成長性、応用性、競合市場シェア、予測（2023年～2032年）

Rare Disease Treatment Market Size By Drug, By Therapeutic Area, By Patient, By Route of Administration, Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章希少疾患治療の業界考察

第4章競合情勢（2021年）

第5章希少疾患治療市場：薬剤タイプ別

第6章希少疾患治療市場：治療領域別

第7章希少疾患治療市場：患者別

第8章希少疾患治療市場：投与経路別

第9章希少疾患治療市場：地域別

第10章企業プロファイル

Charts & Figures

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Rare Disease Treatment Industry Insights

Chapter 4 Competitive Landscape, 2021

Chapter 5 Rare Disease Treatment Market, By Drug Type

Chapter 6 Rare Disease Treatment Market, By Therapeutic Area

Chapter 7 Rare Disease Treatment Market, By Patient

Chapter 8 Rare Disease Treatment Market, By Route of Administration

Chapter 9 Rare Disease Treatment Market, By Region

Chapter 10 Company Profiles

Data Tables

希少疾患治療の市場規模：薬剤タイプ別、治療領域別、患者別、投与経路別－業界分析、地域展望、成長性、応用性、競合市場シェア、予測（2023年～2032年）

Rare Disease Treatment Market Size By Drug, By Therapeutic Area, By Patient, By Route of Administration, Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 希少疾患治療の業界考察

第4章 競合情勢（2021年）

第5章 希少疾患治療市場：薬剤タイプ別

第6章 希少疾患治療市場：治療領域別

第7章 希少疾患治療市場：患者別

第8章 希少疾患治療市場：投与経路別

第9章 希少疾患治療市場：地域別

第10章 企業プロファイル

Charts & Figures

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Rare Disease Treatment Industry Insights

Chapter 4 Competitive Landscape, 2021

Chapter 5 Rare Disease Treatment Market, By Drug Type

Chapter 6 Rare Disease Treatment Market, By Therapeutic Area

Chapter 7 Rare Disease Treatment Market, By Patient

Chapter 8 Rare Disease Treatment Market, By Route of Administration

Chapter 9 Rare Disease Treatment Market, By Region

Chapter 10 Company Profiles

Data Tables

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章希少疾患治療の業界考察

第4章競合情勢（2021年）

第5章希少疾患治療市場：薬剤タイプ別

第6章希少疾患治療市場：治療領域別

第7章希少疾患治療市場：患者別

第8章希少疾患治療市場：投与経路別

第9章希少疾患治療市場：地域別

第10章企業プロファイル